Piramal Life Sciences Acquires Assets of Canadian Medtech Firm BioSyntech for Can $3.9 Million
6/23/2010 7:22:45 AM
SCRIP -- Piramal Healthcare has signed an agreement to acquire the assets of the Canadian medical technology firm, BioSyntech, for a consideration of Can$3.9 million.
|